Navigation Links
Intermountain study finds length of DNA strands can predict life expectancy
Date:3/9/2013

SAN FRANCISCO Can the length of strands of DNA in patients with heart disease predict their life expectancy?

Researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City, who studied the DNA of more that 3,500 patients with heart disease, say yes it can.

In the new study, presented Saturday, March 9, at the American College of Cardiology's Annual Scientific Session in San Francisco, the researchers were able to predict survival rates among patients with heart disease based on the length of strands of DNA found on the ends of chromosomes known as telomeresthe longer the patient's telomeres, the greater the chance of living a longer life.

The study is one of 17 studies from the Intermountain Heart Institute at Intermountain Medical Center that are being presented at the scientific session, which is being attended by thousands of cardiologists and heart experts from around the world.

Previous research has shown that telomere length can be used as a measure of age, but these expanded findings suggest that telomere length may also predict the life expectancy of patients with heart disease.

Telomeres protect the ends of chromosome from becoming damaged. As people get older, their telomeres get shorter until the cell is no longer able to divide. Shortened telomeres are associated with age-related diseases such as heart disease or cancer, as well as exposure to oxidative damage from stress, smoking, air pollution, or conditions that accelerate biologic aging.

"Chromosomes by their nature get shorter as we get older," said John Carlquist, PhD, director of the Intermountain Heart Institute Genetics Lab. "Once they become too short, they no longer function properly, signaling the end of life for the cell. And when cells reach this stage, the patient's risk for age-associated diseases increases dramatically."

Dr. Carlquist and his colleagues from the Intermountain Heart Institute at Intermountain Medical Center tested the DNA samples from more than 3,500 heart attack and stroke patients.

"Our research shows that if we statistically adjust for age, patients with longer telomeres live longer, suggesting that telomere length is more than just a measure of age, but may also indicate the probability for survival. Longer telomere length directly correlate with the likelihood for a longer lifeeven for patients with heart disease," said Dr. Carlquist.

Dr. Carlquist and his colleagues from the Intermountain Heart Institute at Intermountain Medical Center drew on two unique resources that offer unparalleled opportunity for researchers to study the effects of telomere length and survival rates of heart patients:

  • An archive of peripheral blood DNA samples collected from almost 30,000 heart patients, with as much as 20 years of follow-up clinical and survival data. This is stored in Intermountain Healthcare's world-renowned computerized medical informatics record system.

"With so many samples and very complete electronic records, it's a unique resource," said Dr. Carlquist. "It's unmatched in the world, and it allows us to measure the rate of change in the length of a patient's telomeres over time rather than just a snapshot in time, which is typical for most studies."

  • The opportunity to work with experts from around the world, including Richard Cawthon, MD, PhD, who's an international expert on telomere measurement and function.

"I believe telomere length could be used in the future as a way to measure the effectiveness of heart care treatment," said Dr. Carlquist. "We can already test cholesterol and blood pressure of a patient to see how treatment is working, but this could give us a deeper view into how the treatment is affecting the body and whether or not the treatment is working."


'/>"/>

Contact: Jess C. Gomez
jess.gomez@imail.org
801-718-8495
Intermountain Medical Center
Source:Eurekalert

Related biology news :

1. NYBG press publishes final volume of landmark Intermountain Flora series
2. Genetic study of house dust mites demonstrates reversible evolution
3. Bats not bothered by forest fires, study finds
4. International study: Excess dietary salt may drive the development of autoimmune diseases
5. Study pinpoints, prevents stress-induced drug relapse in rats
6. Assembling the transcriptome of a noxious weed: New resources for studying how plants invade
7. Study uncovers enzymes double life, critical role in cancer blood supply
8. Study maps human metabolism in health and disease
9. Volcanic aerosols, not pollutants, tamped down recent Earth warming, says CU-Boulder study
10. Study provides insights into plant evolution
11. New study reveals how sensitive US East Coast regions may be to ocean acidification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - http://photos.prnewswire.com/prnh/20160524/371420 ... ... ... With ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") ... shareholders, Clean Technology Fund I, LP and Clean Technology ... based venture capital funds which together hold approximately 59% ... diluted, as converted basis), that they have entered into ... holdings in Biorem to TUS Holdings Co. Ltd. ("TUS") ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology: